سعر امبرو برو 20 مجم 200 قرص 2025

Ambroxol hydrochloride 20 mg lozenges, pack of 200 (20 strips) from Penta Pharma; listed in Egypt as a mucolytic. In Germany, ambroxol 20 mg lozenges (e.g. Mucoangin) are authorised for relief of acute sore throat pain.

• Pain relief in acute sore throatPopulation: Adults and adolescents over 12 yearsFachinfo-Service (Rote Liste Service GmbH) - German Summary of Product Characteristics (Fachinformation)

• Common: taste disturbance, numbness in mouth and throat, nausea. Uncommon: diarrhoea, upper abdominal pain, dyspepsia, dry mouth. Rare: hypersensitivity reactions, rash, urticaria. Not known: anaphylactic reactions, angioedema, pruritus, severe skin reactions.International label, same formulation · Fachinfo-Service (Rote Liste Service GmbH) - German Summary of Product Characteristics (Fachinformation)

• Hypersensitivity to ambroxol hydrochloride or to any of the excipients.International label, same formulation · Fachinfo-Service (Rote Liste Service GmbH) - German Summary of Product Characteristics (Fachinformation)

• Severe skin reactions (erythema multiforme, SJS/TEN, AGEP) have been reported with ambroxol; stop treatment immediately and seek medical advice if a progressive skin rash (sometimes with blisters or mucosal lesions) occurs.International label, same formulation · Fachinfo-Service (Rote Liste Service GmbH) - German Summary of Product Characteristics (Fachinformation)
• In impaired renal function or severe liver disease, use only on medical advice; accumulation of hepatic metabolites may occur in severe renal insufficiency.International label, same formulation · Fachinfo-Service (Rote Liste Service GmbH) - German Summary of Product Characteristics (Fachinformation)
• Local anaesthetic properties of ambroxol may alter taste perception and cause numbness in the mouth and throat; not authorised for treatment of oral aphthae.International label, same formulation · Fachinfo-Service (Rote Liste Service GmbH) - German Summary of Product Characteristics (Fachinformation)

• Ambroxol crosses the placenta; non-clinical studies and extensive clinical experience after week 28 showed no harmful effects, but usual precautions apply.International label, same formulation · Fachinfo-Service (Rote Liste Service GmbH) - German Summary of Product Characteristics (Fachinformation)
• Ambroxol passes into breast milk in animals; use in breastfeeding women is not recommended.International label, same formulation · Fachinfo-Service (Rote Liste Service GmbH) - German Summary of Product Characteristics (Fachinformation)

English text not available for this section.